Cataract after glaucoma filtration surgery - 28/08/11
Doi : 10.1016/S0002-9394(02)01919-0
Camille Hylton, MD a, Nathan Congdon, MD, MPH a, ⁎ 
, David Friedman, MD, MPH a, John Kempen, MD, PhD b, Harry Quigley, MD a, Eric Bass, MD, MPH c, d, Henry Jampel, MD, MHS a
, David Friedman, MD, MPH a, John Kempen, MD, PhD b, Harry Quigley, MD a, Eric Bass, MD, MPH c, d, Henry Jampel, MD, MHS a a Wilmer Eye Institute, School of Medicine (C.H., N.G., D.F., J.K., H.Q., H.J.), Baltimore, Maryland, USA
b Department of Epidemiology (J.K.), Baltimore, Maryland, USA
c Department of Medicine (E.B.), Baltimore, Maryland, USA
d Department of Health Policy and Management, Bloomberg School of Public Health (E.B.), The Johns Hopkins University, Baltimore, Maryland, USA
*Inquiries to Nathan Congdon, MD, MPH, Johns Hopkins Hospital, Wilmer Rm. 120, 600 N. Wolfe St., Baltimore, MD 21287, USA; fax: (410) 502-8837
Abstract |
Purpose |
We reviewed the evidence regarding cataract incidence and progression after glaucoma surgery.
Design |
Evidence-based review of available literature.
Methods |
We performed a systematic review of relevant studies published in English.
Results |
Reports of visually significant cataract after glaucoma surgery are supported by data from randomized clinical trials and large case series.
Conclusion |
Patients undergoing glaucoma surgery are at increased risk for the development and progression of cataract.
Le texte complet de cet article est disponible en PDF. | We acknowledge support of the Agency for Healthcare Research and Quality (AHRQ), Rockville, Maryland. Dr. Congdon is supported by a Career Development Award from the National Eye Institute (K-23 EY 00388), and a Career Development Award from Research to Prevent Blindness. |
© 2003
Elsevier Science Inc. Tous droits réservés.
Vol 135 - N° 2
P. 231-232 - février 2003 Retour au numéro
Article précédent
- Lenticular fibroxanthomatous nodule
- Seok J. Lee, Jun X. Ling, Thomas M. Aaberg, Hans E. Grossniklaus
- Recurrent retinal vein occlusion in a patient with increased plasma levels of histidine-rich glycoprotein
- Claudia Kuhli, Inge Scharrer, Frank Koch, Lars-Olof Hattenbach
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?